Hughes P, LaRussa P, Pearce J M, Lepow M, Steinberg S, Gershon A
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York 10032.
J Pediatr. 1994 Jun;124(6):932-5. doi: 10.1016/s0022-3476(05)83185-3.
A 5-year-old white boy in remission from acute lymphoblastic leukemia who was receiving maintenance anticancer chemotherapy had approximately 200 vesicular skin lesions 1 month after receiving live attenuated varicella vaccine. About 2 to 3 weeks later, a mild illness resembling varicella occurred in his susceptible siblings and in three of his classmates. Vaccine-type varicella-zoster virus was demonstrated by polymerase chain reaction in swab specimens from vesicular lesions in his two siblings, in whom antibody to varicella-zoster virus also developed.